Registered entities
Bonum Therapeutics, Inc
Reg. No. 87-2883314United States
Bonum Therapeutics, Inc.
Reg. No. 872883314United States
Bonum M
Reg. No. 40003940535Latvia
Bonum US
Reg. No. 40103491406Latvia
Innovation
2 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 338 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Social engagement
Social engagement: 5.9K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Private equity | 1 | 17% |
| Other / undisclosed | 1 | 17% |
Recent activity
27 May 2026
Event
ASCO26
16 Apr 2026
Event
Modifiers of Inflammation and the Tumor Environment session
9 Jan 2026
Event
JPM26